MedPath

Evaluation of free oxygen radicals and effect of Unani treatment in cases of anxiety

Phase 2
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Registration Number
CTRI/2023/09/057254
Lead Sponsor
Ajmal khan tibbiya college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient having mild and moderate anxiety 14 to 24 on the basis of Hamilton Anxiety Rating Scale

Patients between 18 to 60 years

Both sexes

Exclusion Criteria

Pateints suffering from severe or unstable medical condition

Patients suffering from major psychiatric disorders like psychosis and schizophrenia

Pregnant and lactating women

Patient who failed to give consent

Patients of severe anxiety with panic disorder and other anxiety disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hamilton Anxiety Rating Scale for assessment of anxiety <br/ ><br>Serum MDA concentration for oxidative stressTimepoint: Baseline and 6 weeks
Secondary Outcome Measures
NameTimeMethod
Mean platelet volume & platelet count <br/ ><br>platelet distribution width <br/ ><br>red cell distribution widthTimepoint: Assessment before & after treatment
© Copyright 2025. All Rights Reserved by MedPath